Pharmesis International Ltd. provided earnings results guidance for the fourth quarter and financial year 2018. The Group is expected to report a net profit for the unaudited financial results for the fourth quarter and financial year ended 31 December 2018 as compared to a net loss for the corresponding periods for the fourth quarter and financial year ended 31 December 2017. The expected net profit was mainly attributed to higher other income in the fourth quarter of fiscal year and financial year 2018.